行动呼吁:儿童代谢功能障碍相关脂肪性肝病需立即关注以遏制健康危机
儿童代谢功能障碍相关脂肪性肝病(MASLD)近几十年来全球患病率上升,与儿童期显著合并症及青年期早死风险增高40倍相关,已成为美国青年肝移植首要指征。本文指出筛查与分期不足、缺乏准确无创检测和有效药物,源于多中心临床试验匮乏,呼吁通过宣教、多学科诊疗和临床试验等综合措施应对。
要点
- 儿童MASLD与青年期早死风险增高40倍相关,已成为美国青年肝移植首要指征。
- 儿童MASLD筛查与疾病分期实践不足,缺乏准确的无创检测和有效药物治疗。
- 亟需通过宣教、多学科诊疗、社区倡议和临床试验等综合措施应对儿童MASLD。
核心结论
- 儿童MASLD已成为公共卫生危机,亟需全面公共卫生政策控制其流行,并呼吁利益相关方立即行动。
研究设计与样本
- 本文为行动呼吁(Call to Action)类文章,旨在提升对儿童MASLD作为公共卫生危机的认识。
主要发现
- 儿童MASLD近几十年来全球患病率上升,与儿童期显著合并症及青年期早死风险增高40倍相关。
- MASLD已成为美国青年肝移植的首要指征。
- 儿童MASLD的筛查与疾病分期实践不足,缺乏准确的无创检测和有效药物治疗,均源于儿童MASLD多中心临床试验匮乏。
临床怎么用
- 作者建议开展宣教活动,教育和赋能患者及家庭。
- 作者建议解决包括就医可及性在内的障碍,提供营养和运动支持项目,建立多学科诊疗,启动社区倡议。
- 作者建议开展儿童MASLD临床试验,以基于年龄评估新型诊断和治疗选择。
- 作者呼吁制定全面公共卫生政策以控制儿童MASLD流行,并呼吁利益相关方立即行动。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) has become more prevalent on a global scale over the last decades and is associated with significant comorbidities in childhood and a 40-fold higher risk of early mortality in young adulthood. MASLD has now become the leading indication for liver transplantation in young adults in the United States. However, pediatric MASLD is still perceived as an indolent condition by many patients, families, and clinicians. In this Call to Action, we aim to raise awareness of pediatric MASLD as a public health crisis. Herein, we describe insufficient screening and disease staging practices, and a lack of accurate non-invasive tests and effective pharmacotherapy, both stemming from a paucity of multicenter clinical trials in pediatric MASLD. We provide clear steps to address this public health emergency by promoting awareness campaigns, educating and empowering patients and families, addressing barriers including access to care, nutritional and exercise support programs, establishing multidisciplinary care, launching community initiatives, and conducting clinical trials in pediatric MASLD for an age-based evaluation of novel diagnostic and therapeutic options. We conclude by highlighting the urgent need for comprehensive public health policies to control the tide of pediatric MASLD and call upon stakeholders to act now.
引用
- Hartmann P, Mouzaki M, Hassan S, et al. Call to action-Pediatric MASLD requires immediate attention to curb health crisis. Hepatology. 2025. PMID: 40550108. doi:10.1097/HEP.0000000000001440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。